Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 5 |
GO:0005929 | cilium | 4 | 5 |
GO:0042995 | cell projection | 2 | 5 |
GO:0043226 | organelle | 2 | 5 |
GO:0043227 | membrane-bounded organelle | 3 | 5 |
GO:0110165 | cellular anatomical entity | 1 | 5 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 5 |
Related structures:
AlphaFold database: E9B6X7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 31 | 35 | PF00656 | 0.426 |
CLV_PCSK_SKI1_1 | 139 | 143 | PF00082 | 0.269 |
DOC_PP2B_LxvP_1 | 19 | 22 | PF13499 | 0.363 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.502 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.539 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.661 |
LIG_14-3-3_CanoR_1 | 107 | 117 | PF00244 | 0.587 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.670 |
LIG_FHA_1 | 127 | 133 | PF00498 | 0.417 |
LIG_FHA_1 | 25 | 31 | PF00498 | 0.380 |
LIG_FHA_1 | 41 | 47 | PF00498 | 0.440 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.494 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.503 |
LIG_FHA_2 | 66 | 72 | PF00498 | 0.469 |
LIG_LIR_Apic_2 | 115 | 120 | PF02991 | 0.525 |
LIG_LIR_Gen_1 | 54 | 61 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 121 | 127 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 135 | 141 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 54 | 60 | PF02991 | 0.493 |
LIG_SH2_CRK | 124 | 128 | PF00017 | 0.522 |
LIG_SH2_PTP2 | 83 | 86 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 131 | 134 | PF00017 | 0.442 |
LIG_SH2_STAT5 | 83 | 86 | PF00017 | 0.500 |
LIG_SH3_3 | 12 | 18 | PF00018 | 0.457 |
LIG_TRAF2_1 | 112 | 115 | PF00917 | 0.458 |
LIG_TRAF2_1 | 163 | 166 | PF00917 | 0.607 |
LIG_TYR_ITSM | 120 | 127 | PF00017 | 0.427 |
MOD_CK1_1 | 101 | 107 | PF00069 | 0.512 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.522 |
MOD_CK1_1 | 119 | 125 | PF00069 | 0.559 |
MOD_CK1_1 | 184 | 190 | PF00069 | 0.582 |
MOD_CK2_1 | 160 | 166 | PF00069 | 0.627 |
MOD_CK2_1 | 59 | 65 | PF00069 | 0.459 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.391 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.616 |
MOD_GlcNHglycan | 160 | 165 | PF01048 | 0.588 |
MOD_GlcNHglycan | 175 | 179 | PF01048 | 0.513 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.521 |
MOD_NEK2_1 | 10 | 15 | PF00069 | 0.472 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.418 |
MOD_PIKK_1 | 35 | 41 | PF00454 | 0.469 |
MOD_Plk_1 | 101 | 107 | PF00069 | 0.469 |
MOD_Plk_1 | 53 | 59 | PF00069 | 0.534 |
MOD_Plk_4 | 101 | 107 | PF00069 | 0.516 |
MOD_Plk_4 | 127 | 133 | PF00069 | 0.491 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.539 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.659 |
MOD_SUMO_rev_2 | 111 | 120 | PF00179 | 0.406 |
MOD_SUMO_rev_2 | 135 | 141 | PF00179 | 0.469 |
TRG_ENDOCYTIC_2 | 124 | 127 | PF00928 | 0.520 |
TRG_ENDOCYTIC_2 | 138 | 141 | PF00928 | 0.562 |
TRG_ENDOCYTIC_2 | 77 | 80 | PF00928 | 0.431 |
TRG_ENDOCYTIC_2 | 83 | 86 | PF00928 | 0.423 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1ICH3 | Leptomonas seymouri | 53% | 98% |
A0A0S4JM98 | Bodo saltans | 33% | 100% |
A0A1X0P624 | Trypanosomatidae | 32% | 100% |
A0A3Q8IQ44 | Leishmania donovani | 85% | 100% |
A0A422P1B2 | Trypanosoma rangeli | 34% | 100% |
A4HNB6 | Leishmania braziliensis | 73% | 100% |
A4IBY8 | Leishmania infantum | 85% | 100% |
C9ZYL7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |